学术搜索
科研智能体
- Research Labs
- AI 阅读
- AI 文库
- AMiner 沉思
- AMiner 亮点
学术资源
- AI2000
- 期刊/会议
- 学者库
- 学术API
- 溯源树
- 数据集
知识沉淀
- 学术空间

订阅小程序

旧版功能

aminer vip

开通会员低至0.73元/天

一次搞定AI科研

立即登录

a hamlett | AMiner学者主页 | AMiner

a hamlett

EMD Serono Inc

20Papers / 论文

131Citations / 引用

5H-Index

浏览量7

全面呈现 [a hamlett] 的学术影响力

深度挖掘高质量成果与权威引用，让优秀看得见

研究兴趣

暂无数据

论文（20）

专利

基金项目

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1Relapses and lymphocyte counts before and after rescue therapy in the phase III, 96-week, double-blind, placebo-controlled CLARITY study of cladribine tablets for relapsing-remitting multiple sclerosis

P. Soelberg Sorensen,G. Giovannoni,P. Rieckmann,G. Comi,S. Cook,K. Rammohan,P. Vermersch,N. Kurukulasuriya,A. Hamlett,A. Galazka

2011MULTIPLE SCLEROSIS JOURNAL（2011）引用：1

引用

加入学术空间

2Consistent efficacy of cladribine tablets across the spectrum of patients with relapsing-remitting multiple sclerosis of differing severity: data from the 96-week, double-blind CLARITY study

P. Rieckmann,G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Soelberg-Sorensen,P. Vermersch, D. Bock,A. Hamlett,V. Viglietta,B. Musch,S. J. Greenberg

2010EUROPEAN JOURNAL OF NEUROLOGY（2010）

引用

加入学术空间

3Consistent reductions in MRI activity with cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis in the CLARITY study

Stuart D Cook,Gavin Giovannoni,K Rammohan, Peter Rieckmann,P Soelbergsorensen,P Vermersch,A Hamlett,B Musch,T Fevr, Viglietta,Steven Greenberg,Clarity Study Grp

2010EUROPEAN JOURNAL OF NEUROLOGY（2010）引用：23

引用

加入学术空间

4Short Communications

P. Rieckmann,G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Soelberg-Sørensen, P. Vermersch, D. Bock,A. Hamlett,V. Viglietta,B. Musch,S. J. Greenberg,

cancelled

2010European Journal of Neurology（2010）

引用

加入学术空间

5Rapid and Sustained Efficacy with Cladribine Tablet Treatment in Relapsing-Remitting Multiple Sclerosis (rrms): Results from the Clarity Study, A 96-Week, Phase Iii, Double-Blind, Placebo-Controlled Trial

P. Vermersch,G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Rieckmann,P. Soelberg-Sorensen,P. Chang,A. Hamlett,B. Musch,R. Verjee,S. Greenberg

2009JOURNAL OF NEUROLOGY（2009）引用：1

引用

加入学术空间

6Disease-free status achieved with cladribine tablets in the 96-week, phase III, double-blind, placebo-controlled CLARITY study in patients with relapsing-remitting multiple sclerosis

Gavin Giovannoni,Giancarlo Comi,Stuart D Cook,K Rammohan,Peter Rieckmann,Per Soelberg Sorensen,P Vermersch,P Chang,A Hamlett,B Musch,R Verjee,T Fevr,

2009MULTIPLE SCLEROSIS（2009）引用：24

引用

加入学术空间

7Early onset of effect of treatment with cladribine tablets for relapsing-remitting multiple sclerosis in the 96-week, phase III, double-blind, placebo-controlled CLARITY study

P. Vermersch,G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Rieckmann,P. S. Sorensen,P. Chang,A. Hamlett,B. Musch,R. Verjee,S. Greenberg

2009MULTIPLE SCLEROSIS（2009）引用：4

引用

加入学术空间

8Clinical Outcomes Of Short-Course Oral Treatment With Cladribine Tablets For Relapsing-Remitting Multiple Sclerosis (Rrms) In The 96-Week, Phase Iii, Double-Blind, Placebo-Controlled Clarity Study

Giacomo Pietro Comi,Sarah Sheets Cook,Gavin Giovannoni,K. Rammohan, Peter Rieckmann,P. Soelberg-Sørensen,P. Vermersch, Paul A Chang,A. Hamlett,B. Musch,T. Fevr,Vissia Viglietta,

2009JOURNAL OF THE NEUROLOGICAL SCIENCES（2009）引用：2

引用

加入学术空间

9PO10-TU-39 Safety and Tolerability of Short-Course Oral Treatment with Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis (RRMS) in the 96-Week, Phase III, Double-Blind, Placebo-Controlled CLARITY Study

S. Cook,P. Vermersch,G. Comi,G. Giovannoni,K. Rammohan, P. Rieckmann,P. Soelberg-Sorensen,P. Chang,A. Hamlett,B. Musch,V. Viglietta,S. Greenberg

2009Journal of the neurological sciences（2009）引用：6

引用

加入学术空间

10FP36-WE-02 Clinical Outcomes of Short-Course Oral Treatment with Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis (RRMS) in the 96-Week, Phase III, Double-Blind, Placebo-Controlled CLARITY Study

G. Giovannoni,G. Comi,S. Cook,K. Rammohan,P. Rieckmann,P. Soelberg-Sørensen,P. Vermersch,P. Chang,A. Hamlett,B. Musch,S. Greenberg

2009Journal of the Neurological Sciences（2009）引用：1

引用

加入学术空间

11Effects of cladribine tablets on haematological profiles in patients with relapsing-remitting multiple sclerosis in the 96-week, phase III, double-blind, placebo-controlled CLARITY study

P. S. Sorensen,G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Rieckmann,P. Vermersch,P. Chang,A. Hamlett,V. Viglietta,R. Verjee,B. Musch,

2009MULTIPLE SCLEROSIS（2009）引用：2

引用

加入学术空间

12Effects of Cladribine Tablets on Peripheral Lymphocyte Subtypes Implicated in Multiple Sclerosis Immunopathogenesis: Surface Marker Analysis for A Subset of Patients from the 96-Week, Phase Iii, Double-Blind, Placebo-Controlled Clarity Study

P. Rieckmann,G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. S. Sorensen,P. Vermersch,P. Chang,A. Hamlett,V. Viglietta,B. Musch,S. Greenberg

2009MULTIPLE SCLEROSIS（2009）引用：31

引用

加入学术空间

13Haematological profiles in patients treated with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS): results from the CLARITY study, a 96 week, phase III, double-blind, placebo-controlled trial

P Soelbergsorensen,Giancarlo Comi,Stuart D Cook,Gavin Giovannoni,K Rammohan,Peter Rieckmann,P Vermersch, Philip Chang,A Hamlett, Viglietta,Steven Greenberg,Clarity Study Grp

2009JOURNAL OF NEUROLOGY（2009）引用：25

引用

加入学术空间

14Cladribine tablets produce sustained improvements in relapsing-remitting multiple sclerosis in the 96-week, phase III, double-blind, placebo-controlled CLARITY study

K. Rammohan,P. Vermersch,G. Comi,S. Cook,G. Giovannoni,P. Rieckmann,P. S. Sorensen,P. Chang,A. Hamlett,B. Musch,R. Verjee,S. Greenberg

2009MULTIPLE SCLEROSIS（2009）

引用

加入学术空间

15Mri Outcomes Of Short-Course Oral Treatment With Cladribine Tablets For Relapsing-Remitting Multiple Sclerosis (Rrms) In The 96-Week, Phase Iii, Double-Blind, Placebo-Controlled Clarity Study

G. Comi,S. Cook,G. Giovannoni,K. Rammohan, P. Rieckmann,P. Soelberg-Sorensen,P. Vermersch,P. Chang,A. Hamlett,B. Musch,T. Fevr,V. Viglietta,

2009JOURNAL OF THE NEUROLOGICAL SCIENCES（2009）引用：1

引用

加入学术空间

16Magnetic Resonance Imaging (mri) Outcomes in Patients with Relapsing-Remitting Multiple Sclerosis (rrms) Treated with Cladribine Tablets: Results from the Clarity Study, A 96-Week, Phase Iii, Double-Blind, Placebo-Controlled Trial

G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Rieckmann,P. Soelberg-Sorensen,P. Vermersch,P. Chang,A. Hamlett,B. Musch,T. Fevr,S. Greenberg

2009JOURNAL OF NEUROLOGY（2009）引用：2

引用

加入学术空间

17Safety and tolerability of cladribine tablets in relapsing-remitting multiple sclerosis during the 96-week, phase III, double-blind, placebo-controlled CLARITY study

S. Cook,P. Vermersch,G. Comi,G. Giovannoni,K. Rammohan,P. Rieckmann,P. S. Sorensen,P. Chang,A. Hamlett,B. Musch,V. Viglietta,S. Greenberg

2009MULTIPLE SCLEROSIS（2009）引用：3

引用

加入学术空间

18Clinical outcomes with cladribine tablets in the 96-week, phase III, double-blind, placebo-controlled CLARITY study in patients with relapsing-remitting multiple sclerosis

G. Giovannoni,G. Comi,S. Cook,K. Rammohan,P. Rieckmann,P. S. Sorensen,P. Vermersch,P. Chang,A. Hamlett,B. Musch,T. Fevr,S. Greenberg

2009MULTIPLE SCLEROSIS（2009）引用：2

引用

加入学术空间

19FP36-WE-03 MRI Outcomes of Short-Course Oral Treatment with Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis (RRMS) in the 96-Week, Phase III, Double-Blind, Placebo-Controlled CLARITY Study

G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Rieckmann,P. Soelberg-Sørensen,P. Vermersch,P. Chang,A. Hamlett,B. Musch,T. Fevr,V. Viglietta,

2009Journal of the Neurological Sciences（2009）引用：1

引用

加入学术空间

20Reductions in MRI activity in relapsing-remitting multiple sclerosis achieved with cladribine tablets in the 96-week, phase III, double-blind, placebo-controlled CLARITY study

G. Comi,S. Cook,G. Giovannoni,K. Rammohan,P. Rieckmann,P. S. Sorensen,P. Vermersch,P. Chang,A. Hamlett,B. Musch,T. Fevr,V. Viglietta,

2009MULTIPLE SCLEROSIS（2009）引用：2

引用

加入学术空间

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

Kottil Rammohan

Kottil Rammohan合作论文数20

Gavin Giovannoni合作论文数Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London;Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London20

Peter Rieckmann

Peter Rieckmann合作论文数20

P. Vermersch

P. Vermersch合作论文数UMR LIRIC 995, Univ Lille19

Stuart D. Cook

Stuart D. Cook合作论文数18

B. Musch

B. Musch合作论文数18

Comi Giancarlo合作论文数Department of Neurology, Scientific Institute San Raffaele;Institute Experimental Neurology, Scientific Institute San Raffaele;Vita-Salute San Raffaele University17

Steven Greenberg

Steven Greenberg合作论文数Abbvie15

P. Chang

P. Chang合作论文数13

Per Soelberg Sørensen合作论文数Department of Clinical Medicine, University of Copenhagen12

Vissia Viglietta

Vissia Viglietta合作论文数10

T. Fevr

T. Fevr合作论文数8

P. Soelberg-Sorensen

P. Soelberg-Sorensen合作论文数8

R. Verjee

R. Verjee合作论文数5

clarity study grp

clarity study grp合作论文数2

steven greenberg

steven greenberg合作论文数2

N. Kurukulasuriya

N. Kurukulasuriya合作论文数1

M. L. Martin-Barriga

M. L. Martin-Barriga合作论文数1

M. J. Aguilar-Amat

M. J. Aguilar-Amat合作论文数1

G Comi

G Comi合作论文数1

S. J. Greenberg

S. J. Greenberg合作论文数1

Andrew Galazka合作论文数1

L. Gabaldon Torres

L. Gabaldon Torres合作论文数1

p chang

p chang合作论文数1

Stuart Cook合作论文数Duke-NUS Medical School, National University of Singapore;MRC London Institute of Medical Sciences, Faculty of Medicine, Imperial College London1

Sarah Sheets Cook

Sarah Sheets Cook合作论文数1

Giacomo Pietro Comi合作论文数Department of Pathophysiology and Transplantation, University of Milan;Dino Ferrari Center, University of Milan;Faculty of Medicine, University of Milan;UOC Neurology Unit, Fondazione I.R.C.C.S. Ca’ Granda Ospedale Maggiore Policlinico;Motor Neuron Center, Foundation I.R.C.C.S. “Ca’Granda” Ospedale Maggiore Policlinico Hospital1

相似学者

Kottil Rammohan

Kottil Rammohan

Gavin Giovannoni

Peter Rieckmann

Peter Rieckmann

Steven Greenberg

Steven Greenberg

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn